Results 191 to 200 of about 32,623 (326)

Cutaneous lupus erythematosus induced by tislelizumab [PDF]

Weiquan Chen, Xuan Song, Ying Zhou
openalex   +1 more source

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult [PDF]

Advances in Dermatology and Allergology, 2017
Mao, Qiu-Xia, Zhang, Wan-Lu, Wang, Qiang, Xiao, Xue-Min, Chen, Hao, Shao, Xue-Bao, Jia, Hong, Feng, Su-Ying, Wu, Jian-Bing, Li, Cheng-Rang   +9 more
openaire   +2 more sources

Neonatal lupus erythematosus with persistent cutaneous telangiectases

, 1998
Neonatal lupus erythematosus (NLE) is a rare disorder. It is characterized by cutaneous lesions and/or congenital heart block. Hematological abnormalities can be associated.
G. Tribbia, S.Menni
core  

Digital twins to accelerate target identification and drug development for immune‐mediated disorders

FEBS Open Bio, Volume 16, Issue 6, Page 1048-1059, June 2026.
Digital twins integrate patient‐derived molecular and clinical data into personalised computational models that simulate disease mechanisms. They enable rapid identification and validation of therapeutic targets, prediction of drug responses, and prioritisation of candidate interventions.
Anna Niarakis, Philippe Moingeon
wiley   +1 more source

Cutaneous lupus erythematosus - from pathogenesis to targeted therapy. [PDF]

Nat Rev Rheumatol
Klein B, Billi AC, Abernathy-Close L, Kahlenberg JM.   +3 more
europepmc   +1 more source

Role of Prednisone and 25‐Hydroxyvitamin D on Bone Mineral Density and Osteoporosis in Systemic Lupus Erythematosus

Arthritis Care &Research, Volume 78, Issue 6, Page 743-748, June 2026.
Objective We evaluated the role of 25‐hydroxyvitamin D (25[OH]D), prednisone, and other risk factors for bone mineral density (BMD) loss and osteoporosis in systemic lupus erythematosus (SLE). Methods We calculated the association between 25(OH)D levels and other potential risk factors and BMD measures (spine T scores) and osteoporosis (defined as a T ...
Nima Madanchi, Andrea Fava, Daniel W. Goldman, Laurence S. Magder, Michelle Petri   +4 more
wiley   +1 more source

Dyspigmentation and scarring in cutaneous lupus erythematosus. [PDF]

Lupus Sci Med
Chambers S, On A, Yang X, Lopes Almeida Gomes L, Khosravi-Hafshejani T, Ali H, Feng R, Werth VP.   +7 more
europepmc   +1 more source

Nitrendipine-induced subacute cutaneous lupus erythematosus

, 2003
A 66-year-old man presented with widespread annular and bullous subacute cutaneous lupus erythematosus (SCLE), developed after starting treatment for hypertension with the calcium channel blocker nitrendipine.
Caputo, Ruggero, Facchetti, Maura, BORGHI, Alessandro, Marzano, Angelo V, Mercogliano, Maurizio   +4 more
core  

Development and Validation of Algorithms for Systemic Sclerosis Identification in Electronic Health Record Data

ACR Open Rheumatology, Volume 8, Issue 6, June 2026.
Objective The aim of this study was to develop and validate International Classification of Diseases (ICD) code–based algorithms for identifying systemic sclerosis (SSc) cases within electronic health record (EHR) data and to evaluate algorithm performance. Methods We identified patients with at least one ICD, Ninth Revision (ICD‐9)/ICD‐10 code for SSc
Gulsen Ozen, Michael O'Rorke, Paul Romitti, Robyn Domsic   +3 more
wiley   +1 more source

Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials. [PDF]

J Inflamm Res
Wei E, Lopes Almeida Gomes L, Jun S, Saksena S, Werth VP.   +4 more
europepmc   +1 more source